Fig. 6

Testing of the OxiLast™ formulation onto two different coated surfaces in a hospital room at three coating ages (days). (a) test of two hospital isolates of MRSA and K. pneumoniae in the same conditions of the general modeled environmental testing. (b) Testing of the antimicrobial capacity of the formulation against reference ATCC strains in the presence of artificial test soil (ATS, 3 mg/ml) as an organic matrix in the tested inocula. Error bars show standard deviation